1. Home
  2. AERT vs CGTX Comparison

AERT vs CGTX Comparison

Compare AERT & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AERT
  • CGTX
  • Stock Information
  • Founded
  • AERT 2012
  • CGTX 2007
  • Country
  • AERT Singapore
  • CGTX United States
  • Employees
  • AERT N/A
  • CGTX N/A
  • Industry
  • AERT Professional Services
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AERT Consumer Discretionary
  • CGTX Health Care
  • Exchange
  • AERT Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • AERT 25.4M
  • CGTX 30.0M
  • IPO Year
  • AERT N/A
  • CGTX 2021
  • Fundamental
  • Price
  • AERT $0.54
  • CGTX $0.59
  • Analyst Decision
  • AERT
  • CGTX Strong Buy
  • Analyst Count
  • AERT 0
  • CGTX 6
  • Target Price
  • AERT N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • AERT 74.8K
  • CGTX 821.4K
  • Earning Date
  • AERT 02-24-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • AERT N/A
  • CGTX N/A
  • EPS Growth
  • AERT N/A
  • CGTX N/A
  • EPS
  • AERT 0.47
  • CGTX N/A
  • Revenue
  • AERT $70,851,000.00
  • CGTX N/A
  • Revenue This Year
  • AERT N/A
  • CGTX N/A
  • Revenue Next Year
  • AERT N/A
  • CGTX N/A
  • P/E Ratio
  • AERT $1.14
  • CGTX N/A
  • Revenue Growth
  • AERT 16.98
  • CGTX N/A
  • 52 Week Low
  • AERT $0.51
  • CGTX $0.34
  • 52 Week High
  • AERT $2.93
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • AERT 36.05
  • CGTX 39.91
  • Support Level
  • AERT $0.55
  • CGTX $0.57
  • Resistance Level
  • AERT $0.66
  • CGTX $0.68
  • Average True Range (ATR)
  • AERT 0.10
  • CGTX 0.06
  • MACD
  • AERT -0.00
  • CGTX -0.02
  • Stochastic Oscillator
  • AERT 9.81
  • CGTX 7.83

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: